1
|
Ubukata Y (2020) [39] |
No/low and high expression |
CD163 level was determined |
Immunohistochemistry |
2
|
Ju X (2020) [40] |
0 (no staining), 1 (weak staining), 2 (moderate to intense staining). |
CD68 in macrophage was scored as 1 (<1%), 2 (1–9%), 3, or 4 (>20%) |
Immunohistochemistry |
3
|
Junttila A (2020) [41] |
PD-L1 CPS was ≤1% or >1%/Divided into two groups |
Clever-1 was defined to be high when median ≥ 15 in macrophages |
Immunohistochemistry |
4
|
Huang Y.K (2019) [42] |
Low or high expression |
Macrophages were CD68 positive/M1-like TAM populations were identified based on the absence of CD163 and CD206/M2-like TAM populations were identified by the presence of CD163 and/or CD206 |
Immunohistochemistry |
5
|
Harada K (2017) [43] |
PD-L1 positive if >1% of tumor cells expressed PD-L1 |
The density of CD68- and CD163-positive cells was evaluated |
Immunohistochemistry |
6
|
Zhang H (2022) [44] |
Positive or negative PD-L1 expression |
For the CD68+ macrophages density, ≤66/HPF (at ×200 magnification) was defined as low and ≥67/HPF was defined as high/For the IL-10+ CD68+ cells density, ≤9/HPF was defined as low and ≥10/HPF was defined as high. |
Immunohistochemistry |
7
|
Ivanovic T (2023) [45] |
PD-L1-positive tumor cells estimated as negative (0), low |
The density of macrophage infiltration was valued as 0 (no infiltration), 1 (sparse), 2 (peripheral) and 3 (dense and intermingled with tumor cells) |
Immunohistochemistry |